Miss Nattaporn Phanthaphol
- Visiting Research Fellow (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546)
Somboonpatarakun, C., Phanthaphol, N., Suwanchiwasiri, K., Ramwarungkura, B., Yuti, P., Poungvarin, N., Thuwajit, P., Junking, M. and Yenchitsomanus, P.-T. (2024) Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer. International Immunopharmacology, 129, 111631. (doi: 10.1016/j.intimp.2024.111631) (PMID:38359664)
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546)
Somboonpatarakun, C., Phanthaphol, N., Suwanchiwasiri, K., Ramwarungkura, B., Yuti, P., Poungvarin, N., Thuwajit, P., Junking, M. and Yenchitsomanus, P.-T. (2024) Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer. International Immunopharmacology, 129, 111631. (doi: 10.1016/j.intimp.2024.111631) (PMID:38359664)